ArticleCancers2023

Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study.

Ioannis Petrakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.